Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2) Source: Annual Congress 2010 - COPD: management Year: 2010
Prevalence and predictive factors of sleep apnea syndrome (SAS) in type 2 diabetic patients with poor diabetic control Source: Eur Respir J 2006; 28: Suppl. 50, 648s Year: 2006
Screening for diabetes mellitus in patients with OSAS: a case for glycosylated haemoglobin Source: Eur Respir J 2012; 40: 273-274 Year: 2012
Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012
Association between continuous positive airway pressure, weight change and glycaemic control in patients with type 2 diabetes Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020
COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008
Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005
Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients Source: Eur Respir J 2007; 30: Suppl. 51, 365s Year: 2007
Severe sleep apnea, type 2 diabetes and beneficial effects of CPAP on nocturnal glucose control Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004
Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016
A hospital based study of sleep in metabolic syndrome between obese & non obese North Indians Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Effect of inhaled human insulin (EXUBERA®; EXU) vs subcutaneous insulin (SC) on lung lining fluid constituents in adults with type 1 diabetes mellitus (T1DM) Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007
Glucose metabolism markers in non-diabetic OSAS patients. Effect of compliance to CPAP treatment Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012
Presence of diabetic autonomic neuropathy in children with type 1 diabetes mellitus is associated with the significant decrease of cough reflex sensitivity Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Prevalence and characteristics of Sleep Disordered Breathing in a group of 483 patients with type 2 diabetes Source: International Congress 2017 – Lung function, respiratory symptoms and obstructive sleep apnoea Year: 2017
The relationship between lung function and blood glucose control in type 2 diabetic patients Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008